{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T04:48:34Z","timestamp":1769057314872,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.eplepsyres.2024.107380","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T16:22:17Z","timestamp":1715703737000},"page":"107380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Conventional and novel anti-seizure medications reveal a particular role for GABAA in a North Sea progressive myoclonus Epilepsy Drosophila model"],"prefix":"10.1016","volume":"203","author":[{"given":"Sjoukje S.","family":"Polet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom J.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roald A.","family":"Lambrechts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina A.J.","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ody C.M.","family":"Sibon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenke A.","family":"Gorter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.eplepsyres.2024.107380_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/mdc3.12372","article-title":"Deep brain stimulation in three related cases of North Sea progressive myoclonic Epilepsy from South Africa","volume":"4","author":"Anderson","year":"2017","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.eplepsyres.2024.107380_bib2","doi-asserted-by":"crossref","unstructured":"Boiss\u00e9 Lomax, L., Bayly, M.A., Hjlagrim, H., M\u00f8ller, R.S., Vlaar, A.M., Aaberg, K.M., Marquardt, I., Gandolfo, L.C., Willemsen, M., Kamsteeg, E.J., O'Sullivan, J.D., Korenke, G.C., Bloem, B.R., de Coo, I.F., Verhagen, J.M., Said, I., Prescott, T., Stray-Pedersen, A., Rasmussen, M., Vears, D.F., Berkovic, S.F., 2013. \u2018North Sea\u2019 Progressive Myoclonus Epilepsy: Phenotype of Subjects With GOSR2 Mutation. 136, 1146-1154. \u3008https:\/\/doi.org\/10.1093\/brain\/awt021\u3009.","DOI":"10.1093\/brain\/awt021"},{"issue":"4","key":"10.1016\/j.eplepsyres.2024.107380_bib3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/ph15040475","article-title":"Levetiracetam mechanisms of action: from molecules to systems","volume":"15","author":"Contreras-Garc\u00eda","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.eplepsyres.2024.107380_bib4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ajhg.2011.04.011","article-title":"A mutation in the golgi Qb-SNARE gene GOSR2 causes progressive myoclonus epilepsy with early Ataxia","volume":"88","author":"Corbett","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.eplepsyres.2024.107380_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13023-017-0595-3","article-title":"The efficacy of the modified Atkins diet in North Sea progressive myoclonus Epilepsy: an observational prospective open-label study","volume":"12","author":"van Egmond","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.eplepsyres.2024.107380_bib6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/acn3.334","article-title":"Mutation of orthologous prickle genes causes a similar epilepsy syndrome in flies and humans","volume":"3","author":"Ehaideb","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2024.107380_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s43141-021-00224-0","article-title":"GABAA receptors: structure, function, pharmacology, and related disorders","volume":"19","author":"Ghit","year":"2021","journal-title":"J. Genet. Eng. Biotechnol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2024.107380_bib8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic acid pathway: pharmacokinetics and pharmacodynamics","volume":"23","author":"Ghodke-Puranik","year":"2013","journal-title":"Pharmacogenet.\u00a0Genom."},{"issue":"2","key":"10.1016\/j.eplepsyres.2024.107380_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1527-3458.2007.00009.x","article-title":"Ethosuximide: from bench to bedside","volume":"13","author":"G\u00f6ren","year":"2007","journal-title":"CNS Drug Rev."},{"issue":"2","key":"10.1016\/j.eplepsyres.2024.107380_bib10","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J."},{"issue":"3","key":"10.1016\/j.eplepsyres.2024.107380_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1055\/s-0035-1552620","article-title":"Progressive myoclonus Epilepsies","volume":"35","author":"K\u00e4lvi\u00e4inen","year":"2015","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.eplepsyres.2024.107380_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2019.10.035","article-title":"North Sea progressive myoclonus Epilepsy is exacerbated by heat, a phenotype primarily associated with affected Glia","volume":"423","author":"Lambrechts","year":"2019","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.eplepsyres.2024.107380_bib13","first-page":"329","article-title":"The history of barbiturates a century after their clinical introduction","volume":"1","author":"L\u00f3pez-Mu\u00f1oz","year":"2005","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"Suppl 8","key":"10.1016\/j.eplepsyres.2024.107380_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/epi.12025","article-title":"How theories evolved concerning the mechanism of action of barbiturates","volume":"53","author":"L\u00f6scher","year":"2012","journal-title":"Epilepsia"},{"issue":"6653","key":"10.1016\/j.eplepsyres.2024.107380_bib15","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/39923","article-title":"A Snare involved in protein transport through the Golgi apparatus","volume":"389","author":"Lowe","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.eplepsyres.2024.107380_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ana.410280129","article-title":"Classification of progressive myoclonus epilepsies and related disorders","volume":"28","author":"Marseille Consensus Group","year":"1990","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.eplepsyres.2024.107380_bib17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1055\/s-0040-1719077","article-title":"Ketogenic diet therapies for seizures and status epilepticus","volume":"40","author":"McDonald","year":"2020","journal-title":"Semin Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2024.107380_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/epi4.12669","article-title":"The efficacy and safety of ganaxolone for the treatment of refractory epilepsy: a meta-analysis from randomized controlled trials","volume":"8","author":"Meng","year":"2023","journal-title":"Epilepsia Open"},{"issue":"6","key":"10.1016\/j.eplepsyres.2024.107380_bib19","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/ana.26493","article-title":"Ganaxolone versus Phenobarbital for Neonatal seizure management","volume":"92","author":"Miller","year":"2022","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2024.107380_bib20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/molecules27010104","article-title":"Insights into structural modifications of valproic acid and their pharmacological profile","volume":"27","author":"Mishra","year":"2021","journal-title":"Molecules"},{"issue":"Suppl 2","key":"10.1016\/j.eplepsyres.2024.107380_bib21","first-page":"17","article-title":"Pharmacology of valproate","volume":"37","author":"Owens","year":"2003","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.eplepsyres.2024.107380_bib22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.parkreldis.2020.02.005","article-title":"A detailed description of the phenotypic spectrum of North Sea progressive myoclonus Epilepsy in a large cohort of seventeen patients","volume":"272","author":"Polet","year":"2020","journal-title":"Park. Relat. Disord."},{"issue":"4","key":"10.1016\/j.eplepsyres.2024.107380_bib23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/neu.10297","article-title":"Treatment with the antiepileptic drugs phenytoin and gabapentin ameliorates seizure and paralysis of Drosophila bang-sensitive mutants","volume":"58","author":"Reynolds","year":"2004","journal-title":"J. Neurobiol."},{"issue":"Suppl Suppl 2","key":"10.1016\/j.eplepsyres.2024.107380_bib24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/epi4.12268","article-title":"Brief history of anti-seizure drug development","volume":"3","author":"Rho","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.eplepsyres.2024.107380_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/2398212819858249","article-title":"A half century of \u03b3-aminobutyric acid","volume":"3","author":"Smart","year":"2019","journal-title":"Brain Neurosci. Adv."},{"issue":"2","key":"10.1016\/j.eplepsyres.2024.107380_bib26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/157015909788848929","article-title":"Truly rational\u00a0polytherapy: maximizing efficacy and minimizing drug interactions, drug load, and adverse effects","volume":"7","author":"St Louis","year":"2009","journal-title":"Curr. Neuropharmacol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2024.107380_bib27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tins.2011.01.004","article-title":"Hooked on benzodiazepines: GABAA receptor subtypes and addiction","volume":"34","author":"Tan","year":"2011","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.eplepsyres.2024.107380_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ajhg.2010.12.012","article-title":"Mutations in prickle orthologs cause seizures in flies, mice, and humans","volume":"88","author":"Tao","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.eplepsyres.2024.107380_bib29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/mds.25704","article-title":"Ramsay hunt syndrome: clinical characterization of progressive myoclonus Ataxia caused by GOSR2 mutation","volume":"29","author":"Van Egmond","year":"2014","journal-title":"Mov. Disord."},{"issue":"Suppl 2","key":"10.1016\/j.eplepsyres.2024.107380_bib30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/epi.13999","article-title":"Intramuscular allopregnanolone and ganaxolone in a mouse model of treatment-resistant status epilepticus","volume":"59","author":"Zolkowska","year":"2018","journal-title":"Epilepsia"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121124000950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121124000950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T23:58:50Z","timestamp":1717631930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121124000950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":30,"alternative-id":["S0920121124000950"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2024.107380","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conventional and novel anti-seizure medications reveal a particular role for GABAA in a North Sea progressive myoclonus Epilepsy Drosophila model","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2024.107380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107380"}}